RANI
NSDRani Therapeutics Holdings Inc.
Manufacturing•Medicinal and Botanical Manufacturing
Watchlists:
Last updated: Friday 18th July 2025
0.42
+0.01 (1.68%)
Prev Close:0.41
Open:0.41
Bid:0.41
Ask:0.415
52 Week Range
0.393.84
Volume:1,652,796
Mkt Cap:25 M
33
MarketXLS Rank ®
Weak Hold
Price Target
$0.48
+15.1%
Financial Statements
RANI - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Invalid date | |
|---|---|---|---|---|---|
| Asset Impairment Charge | 2 M | -2 M | |||
| Capital Expenditure Reported | 2 M | 506000.0 | |||
| Cash Flow From Continuing Investing Activities | 20 M | 30 M | -72 M | -506000.0 | |
| Change In Account Payable | 711000.0 | -595000.0 | 163000.0 | 524000.0 | |
| Change In Accrued Expense | 350000.0 | -540000.0 | 605000.0 | 739000.0 | |
| Change In Payables And Accrued Expense | 1 M | -1 M | 768000.0 | 1 M | |
| Change In Prepaid Assets | 631000.0 | 282000.0 | 505000.0 | -2 M | |
| Change In Working Capital | 1 M | -853000.0 | 1 M | -3 M | |
| Depreciation And Amortization | 3 M | 2 M | 538000.0 | 497000.0 | |
| Financing Cash Flow | 14 M | 233000.0 | 29 M | 77 M | |
| Gain Loss On Sale Of PPE | 65000.0 | ||||
| Income Tax Paid Supplemental Data | 48000.0 | 73000.0 | |||
| Interest Paid Supplemental Data | 730000.0 | 285000.0 | |||
| Issuance Of Capital Stock | 46000.0 | 74 M | |||
| Issuance Of Debt | 30 M | -2 M | |||
| Net Common Stock Issuance | 46000.0 | 74 M | |||
| Net Investment Properties Purchase And Sale | -71 M | ||||
| Net Investment Purchase And Sale | -71 M | ||||
| Net Issuance Payments Of Debt | 30 M | -2 M | |||
| Net Long Term Debt Issuance | 30 M | -3 M | |||
| Net PPE Purchase And Sale | -2 M | -506000.0 | |||
| Net Preferred Stock Issuance | 6 M | ||||
| Other Non-cash Items | 17 M | 15 M | 15 M | 23 M | |
| Preferred Stock Issuance | 6 M | ||||
| Proceeds From Issuance Of Warrants | 26000.0 | ||||
| Purchase Of Investment | -74 M | ||||
| Purchase Of PPE | -2 M | -506000.0 | |||
| Repayment Of Debt | -3 M | ||||
| Sale Of Investment | 3 M | ||||
| Short Term Debt Issuance | 2 M | ||||
| Stock Based Compensation | 16 M | 19 M | 16 M | 23 M | |
| Unrealized Gain Loss On Investment Securities | 371000.0 | ||||
| Amord | 2 M | 1 M | -10000.0 | ||
| Begcash | 117 M | 73 M | |||
| Capex | -2 M | -506000.0 | |||
| Cffcf | 14 M | 233000.0 | 29 M | 77 M | |
| Cffinv | 20 M | 30 M | -72 M | -506000.0 | |
| Cffoa | -35 M | -51 M | -47 M | -34 M | |
| Chgcash | -2 M | -21 M | -90 M | 44 M | |
| Chgothcl | -428000.0 | -3 M | |||
| Chgpay | 711000.0 | -595000.0 | 163000.0 | 524000.0 | |
| Comstkiss | 46000.0 | 74 M | |||
| Depamor | 1 M | 822000.0 | 548000.0 | 497000.0 | |
| Endcash | -35 M | -51 M | 28 M | 117 M | |
| Fcf | -35 M | -51 M | -48 M | -33 M | |
| Ltdebtiss | 30 M | ||||
| Ltdebtpay | -3 M | ||||
| Netinccont | -57 M | -68 M | -63 M | -53 M | |
| Netothfin | -615000.0 | -1 M | |||
| Netstdebtiss | 2 M | ||||
| Opcf | -35 M | -51 M | -47 M | -32 M | |
| Opgainloss | 65000.0 | -700000.0 | |||
| Purchsti | -74 M | ||||
| Salesti | 3 M |